Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2014, Vol. 41 Issue (1): 67-71    DOI: 10.12891/ceog16442014
Original Research Previous articles | Next articles
The criterion value of fetal cerebral lateral ventricular atrium width for diagnosis of ventriculomegaly
G. Goynumer1, *(), M. Yayla2, R. Arisoy2, O. Turkmen1
1Istanbul Medeniyet University Goztepe Education and Research Hospital, Istanbul
2Istanbul International Hospital, Istanbul (Turkey)
Download:  PDF(203KB)  ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Aim: To determine the distribution of cerebral lateral ventricular atrium width (LVAW) as established according to gestational weeks, and calculate the criterion value of LVAW that differentiates normal fetuses from abnormal fetuses. Materials and Methods: A total of 832 patients meeting the study's criteria were included in the control group. An additional 43 fetuses with LVAW > ten mm formed the case group. Results: The criterion value of LVAW was 9.7 mm. It did not change significantly throughout gestation. In the case group, 23 fetuses were terminated for fetal abnormalities, two fetuses died in utero, and 18 infants were born alive. Most of the abnormal development coincided with LVAW values greater than 12 mm. Conclusion: The authors suggest 9.7 mm as the criterion value, based on receiver operating characteristic (ROC) curve analysis. When the LVAW is between 9.8 and 12 mm without other fetal abnormalities, it may be regarded as a variation of the normal.
Key words:  Ventriculomegaly      Criterion value      Ultrasonography      Prenatal diagnosis     
Published:  10 February 2014     
*Corresponding Author(s):  G. GOYNUMER     E-mail:  goynumergo@gmail.com

Cite this article: 

G. Goynumer, M. Yayla, R. Arisoy, O. Turkmen. The criterion value of fetal cerebral lateral ventricular atrium width for diagnosis of ventriculomegaly. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(1): 67-71.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog16442014     OR     https://ceog.imrpress.com/EN/Y2014/V41/I1/67

[1] Anjeza Xholli, Anna Biasioli, Giovanni Grandi, Angelo Cagnacci. Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1186-1192.
[2] Thanakorn Heetchuay, Thotsapon Trakulmungkichkarn, Noel Pabalan, Nutthaphon Imsom-Somboon. Reference values of fetal atrioventricular time intervals derive from antegrade late diastolic arterial blood flow (ALDAF) from 14 to 40 weeks of gestation[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 867-874.
[3] Özgür Koçak, Cem Koçak. Finding the best formulas to estimate fetal weight based on ultrasound for the Turkish population: a comparison of 24 formulas[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 676-685.
[4] Saša Raičević, Duško Kljakić, Filip Vukmirović, Miloš Z. Milosavljević. A giant placental chorioangioma with a resultant live birth; a discussion of management options[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 426-430.
[5] Xiao-Hua Li, Jian-Kun Zhou, Jing-Dan Cheng. Application of ultrasound in hepatic pregnancy: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 434-438.
[6] Suchaya Luewan, Pakorn Chaksuwat, Tip Pongsuvareeyakul, Theera Tongsong. Prenatal sonographic findings and management of placental mesenchymal dysplasia[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 439-443.
[7] Sureyya Saridas Demir, Erkan Cağliyan, Sabahattin Altunyurt. Retrospective analysis of pregnancy terminations and indications in a tertiary center[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 85-90.
[8] Y.J. Wu, C.J. Yu, W.H. Tian, Z. Xu. Prenatal diagnosis and molecular cytogenetic characterization of two hereditary chromosomal duplications with favorable outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 789-791.
[9] Y. Wang, X.Y. Lu, F. Xu, H.M. Huang, Y. Xu, X.W. Xi. Detection of uterine artery hemodynamic changes in patients with gestational hypertension based on Doppler ultrasonography[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 584-589.
[10] B.F. Zhou, C.X. Duan, D.L. Tang. Methylmalonic acidemia in prenatal diagnosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 617-619.
[11] M. Özsürmeli, M. Sucu, E. Arslan, S. Büyükkurt. Perinatal outcome of fetuses with echogenic intracardiac focus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 372-375.
[12] D. Lu, D. Cao, Q. Zhao, X. Chen. Prenatal diagnosis and genetic counseling of mosaicism for chromosome t (7; 14) with a favorable outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 427-428.
[13] W. B. Wang, Q. Wu, Y. Zhou, X. Zhong, Y. Ge, J. Zhang. A 10-year retrospective study on prenatal cytogenetic analyses[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 248-252.
[14] Q.C. Wu, W.B. Wang, L. Sun, Y.S. Xu, X.J. Xie, X.M. Ma, Z.Y. Su. Mutation analysis of the fibroblast growth factor receptor 3 gene in fetuses with thanatophoric dysplasia, type I[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 7-11.
[15] G. Szabó, J. Rigó Jr.. Prenatal ultrasound diagnosis of abdominal pregnancy of ovarian origin[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 977-979.
No Suggested Reading articles found!